A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Friday, October 23, 2026
Tag: Neurodegenerative Disease Drugs
Alzheimer’s Blockbuster Is Coming, but Slowly
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
Eli Lilly Results Signal Arrival of Blockbuster New Drug Class
ShareListen(2 min)
Why a $158,000 Drug With Unclear Benefits Hurts Whole Health System
Like many patients suffering from amyotrophic lateral sclerosis, or ALS—also known as Lou Gehrig’s disease—Layne Oliff didn’t have any time ...
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.